CD274 and neoplasm: Our mouse models loosely align with this trend, as the models with detectable immune infiltrates and PD-L1 expression (RENCA, EMT6, and CT26) have higher non-synonymous mutation counts while the poorly infiltrated B16F10 model has the least tumor mutations.